We review the experimental and clinical approaches to depletion strategies and outline some of the pitfalls of depletion, such as limitations of currently available agents, duration of tolerance, infection, and malignancy.
Indeed, neither intra-abdominal surgery, previous exposure to azole agents, duration of central venous catheter implantation, nor female gender were associated with non- albicans Candida infection.
However, the dose of antifungal agents, duration of treatment, and endpoints to assess clinical efficacy have never been published or even discussed.
Previous exposition to azole agents, duration of central venous catheter implantation and the number of antimicrobial agents per day were associated with non- albicans Candida infection in multivariate analyses.
In the first part of the study, a medical questionnaire was filled for every patient including demographic data, the type of diabetes, duration of the disease, type of therapy whether to use insulin or oral hypoglycemic agents, duration and current dose of drug usage.
The activity of bevacizumab in ROC evokes considerable potential for future therapeutic strategies although refinement of details such as optimal timing of treatment, combinations with other agents, duration of treatment and payment for this is urgently required to inform safest and best practice.
The factors studied were: age, gender, length of stay in the ICU, origin of patient (for example, home or transferred from another institution), APACHE II score, adjusted mortality score, previous colonization with MDR, prior use of antimicrobial agents, duration of ventilator use, immunosuppression, diabetes, hypoproteinemia and presence of central venous catheter (CVC).
The effects of four experimental factors were investigated on the fatty acid concentrations and on the recovery of acidification activity of S. thermophilus stored at –20°C by using a complete experimental design: incorporating oleic acid in the culture medium, fermentation pH, addition of glycerol as cryoprotective agent and duration of storage.
Optimal agent, dose, duration, route and frequency of treatment are uncertain.
The i.v. antibiotics (agent and duration) were determined by the attending physician.
Treatment details were requested at each line, including agent dose, duration, and administration route.
